Indication

Unresectable hepatic metastatic uveal melanoma

Unresectable hepatic metastatic uveal melanoma is an advanced, life-threatening clinical stage of ocular melanoma characterized by hematogenous dissemination of malignant intraocular melanocytes to the hepatic parenchyma that cannot be completely eradicated by surgical resection. Read more about Unresectable hepatic metastatic uveal melanoma

3 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Unresectable hepatic metastatic uveal melanoma therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Unresectable hepatic metastatic uveal melanoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Unresectable hepatic metastatic uveal melanoma.

Unresectable hepatic metastatic uveal melanoma is an advanced, life-threatening clinical stage of ocular melanoma characterized by hematogenous dissemination of malignant intraocular melanocytes to the hepatic parenchyma that cannot be completely eradicated by surgical resection.

This condition primarily affects adults diagnosed with primary uveal melanoma, an intraocular malignancy with a pronounced tropism for the liver, which is the initial or dominant site of metastasis in up to 90% of advanced cases.

Pathophysiologically, the tumor cells form diffuse, infiltrative, or multifocal liver lesions that progressively disrupt normal hepatic architecture and vascular flow.

Clinical manifestations include upper abdominal discomfort, hepatomegaly, fatigue, and progressive liver dysfunction, which frequently leads to hepatic failure as the primary cause of disease-related mortality.

Personalize your experience

Follow Unresectable hepatic metastatic uveal melanoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it